Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

November 23, 2011

A Focus on Life Sciences

Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…

Posted by James A. Datin

November 21, 2011

The Power of emPower!

PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…

Posted by James A. Datin

November 18, 2011

Week in Review: Convergence between Life Sciences and Technology and A Look at New Partner Company Medivo

The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…

Posted by John E. Shave III

November 17, 2011

Celebrating Global Entrepreneurship Week and NFTE Philadelphia’s Visionary Gala

Monday marked the start of Global Entrepreneurship Week, a growing movement to motivate aspiring entrepreneurs, help expand networks, and foster entrepreneurial ecosystems. The initiative kicked…

Posted by Sylvia Watts McKinney

November 15, 2011

Opportunity in the Migraine Market for NuPathe

Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…

Posted by James A. Datin

November 11, 2011

Anatomy of a Deal: Advanced BioHealing

Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…

Posted by James A. Datin

November 8, 2011

The Developing Pet Generics Market: A Look at New Partner Company Putney

In America, there are more than 171 million dogs and cats in over 71 million households. Ninety-six percent of the drugs approved for these pets…

Posted by James A. Datin

November 4, 2011

Week in Review: Venture Capital Growth and MediaMath on the Talent Gap

According to a report published by Cambridge Associates LLC, private equity and venture capital funds in the U.S. continued to generate positive returns for their…

Posted by John E. Shave III

October 26, 2011

Recap: Safeguard Scientifics Q3 2011 Financial Results

As Peter J. Boni highlighted this morning, despite volatile capital markets and a wobbly economy, Safeguard Scientifics continues to fire on all cylinders by realizing…

Posted by John E. Shave III

Content